Clinical Trial Update: SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 SPECT study investigating the NMDA receptor system in healthy volunteers and patients with schizophrenia; the trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 1 | Status: TERMINATED